health
Early detection and access to innovative therapies are key to longer life for melanoma patients
It is estimated that the incidence of melanoma, the most dangerous type of skin cancer, is increasing by 15 percent every five years. It is also concerning that our country is still in first place in Europe for melanoma mortality, and it is evident that this disease is still diagnosed late in our country, which significantly worsens treatment outcomes, emphasized today representatives of the Association of Patients with Melanoma (UPOM) at a press conference dedicated to marking Melanoma Awareness Month, where it was highlighted that early detection, prevention, and timely access to modern therapies are crucial for a longer and better quality of life for patients. Participants agreed that it is necessary to systematically regulate the introduction of innovative drugs to the positive list, and that every new therapy in the treatment of melanoma has significantly extended the lifespan of patients so far.
TL;DR
- Melanoma incidence is projected to increase by 15% every five years.
- Serbia leads Europe in melanoma mortality, with late diagnosis significantly impacting treatment success.
- Early detection, prevention, and timely access to modern therapies are crucial for improving patient outcomes.
- Innovative therapies have significantly extended the lifespan and quality of life for melanoma patients.
- There is a need to systematically regulate the introduction of innovative drugs onto the positive list.
- Combined immunotherapy, a global therapeutic standard, could significantly change treatment outcomes in Serbia.
- Systemic and transparent regulation of innovative therapy introduction, including a dedicated budget line, is needed.
- Collaboration between patient associations, medical professionals, regulatory bodies, and the state is essential.